Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Leukemia 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Blast Crisis 8Leukemia, Myeloid, Acute 6Philadelphia Chromosome 5Leukemia, Myeloid, Accelerated Phase 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myeloproliferative Disorders 4Multiple Myeloma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Burkitt Lymphoma 4Primary Myelofibrosis 3Lymphoma 3Leukemia, Biphenotypic, Acute 3Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Hypereosinophilic Syndrome 2Hodgkin Disease 2Hematologic Neoplasms 2Waldenstrom Macroglobulinemia 1Thymoma 1Thrombocytosis 1Thrombocythemia, Essential 1Small Cell Lung Carcinoma 1Sezary Syndrome 1

Interventions

Cyclophosphamide 13fludarabine 9fludarabine phosphate 7Bendamustine Hydrochloride 5Rituximab 4Busulfan 4ibrutinib 3Tacrolimus 3Mycophenolic Acid 3Melphalan 3Bortezomib 3AP 1903 reagent 3tetulomab tetraxetan lu-177 2ponatinib 2cobomarsen 2Whole-Body Irradiation 2Vorinostat 2Vincristine 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mesna 2Lutetium 2Etoposide 2Doxorubicin 2Brentuximab Vedotin 2Bone Marrow Transplantation 2pembrolizumab 1ibritumomab tiuxetan 1enzalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immune System Diseases × Imatinib Mesylate × Lymphoid × Clear all
NCT01650805 2014-11-17

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Ariad Pharmaceuticals

Phase 3 Terminated
307 enrolled 11 charts
LymphoidMyeloidOther hematologic neoplasm

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Myeloid, Lymphatic Diseases, Lymphoproliferative Disorders, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡